Serum Institute of India

Serum Institute of India has expanded its strategic partnership with Bavarian Nordic, taking on the manufacturing of the chikungunya vaccine. This agreement strengthens its position as a global vaccine manufacturer and opens up future co-development opportunities.

Serum Institute of India, which manufactures an indigenous HPV vaccine called Cervavac, might face competition from the government's decision to use Merck & Co.===Gardasil for the national program, potentially limiting Cervavac's market share in the public sector.